Gencurix (XKRX:229000) Marketable Securities : ₩0 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Gencurix Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Gencurix's Marketable Securities for the quarter that ended in Mar. 2024 was ₩0 Mil.

Gencurix's annual Marketable Securities declined from Dec. 2021 (₩10,000 Mil) to Dec. 2022 (₩103 Mil) but then increased from Dec. 2022 (₩103 Mil) to Dec. 2023 (₩8,345 Mil).

Gencurix Marketable Securities Historical Data

The historical data trend for Gencurix's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gencurix Marketable Securities Chart

Gencurix Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

No Debt

103.45

8,345.00

Gencurix Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															79.02	6,500.00	3,000.00	8,345.00	-

Gencurix Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Gencurix (XKRX:229000) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Gencurix Marketable Securities Related Terms

Thank you for viewing the detailed overview of Gencurix's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Gencurix (XKRX:229000) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Gencurix Inc (XKRX:229000) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

9th Floor, Hanhwa Bizmetro I, Guro 3-dong, Guro-gu, Seoul, KOR, 152-733

Website

http://www.gencurix.com

Gencurix Inc develops diagnosis treatment kits. It offers products including GenesWell BCT, a breast cancer test; GenesWell ddEGFR Mutation Test; GenesWell CDx EGFR Mutation Test; and GenesWell ddEGFR mutation Test.

Gencurix (XKRX:229000) Headlines

No Headlines